PentaBase Revenue and Competitors
Estimated Revenue & Valuation
- PentaBase's estimated annual revenue is currently $7M per year.
- PentaBase's estimated revenue per employee is $155,000
Employee Data
- PentaBase has 45 Employees.
- PentaBase grew their employee count by -25% last year.
PentaBase's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director, Products and Medical Devices | Reveal Email/Phone |
PentaBase Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7M | 45 | -25% | N/A | N/A |
What Is PentaBase?
PentaBase is a knowledge-based Danish pharmacogenomics company founded and managed by researchers and located in the heart of Denmark. We specialise in custom oligonucleotide production and the development of in vitro diagnostic assays for real-time PCR with a special focus on the detection of somatic mutations in cancer and COVID-19. For more than 10 years, PentaBase has created products for researchers and medical professionals exploring new treatments and helping patients worldwide. Our products are given unique abilities in the analysis and manipulation of genetic material with our proprietary technology, INAs® (Intercalating Nucleic Acids). Medical professionals and researchers use these features to help treat diseases and acquire new knowledge. We believe in open-platform designs and strive to make our products compatible with basic instruments used in molecular biology facilities worldwide. For more information, please contact us at: Tel: +45 3696 9496 Mail: [email protected] https://www.pentabase.com/
keywords:N/A
N/A
Total Funding
45
Number of Employees
$7M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Odense
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.5M | 53 | 20% | N/A |
#2 | $9.4M | 58 | 26% | N/A |
#3 | $8.8M | 63 | 19% | N/A |
#4 | $25.5M | 63 | 21% | N/A |
#5 | $6.4M | 65 | 27% | N/A |